124 related articles for article (PubMed ID: 36168721)
21. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
[TBL] [Abstract][Full Text] [Related]
22. XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro.
Brooks TD; Wang SW; Brünner N; Charlton PA
Anticancer Drugs; 2004 Jan; 15(1):37-44. PubMed ID: 15090742
[TBL] [Abstract][Full Text] [Related]
23. The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Ismail AA; Shaker BT; Bajou K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008762
[TBL] [Abstract][Full Text] [Related]
24. Hyperglycemia impairs cytotrophoblast function via stress signaling.
Cawyer CR; Horvat D; Leonard D; Allen SR; Jones RO; Zawieja DC; Kuehl TJ; Uddin MN
Am J Obstet Gynecol; 2014 Nov; 211(5):541.e1-8. PubMed ID: 24793974
[TBL] [Abstract][Full Text] [Related]
25. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
[TBL] [Abstract][Full Text] [Related]
26. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F
Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105
[TBL] [Abstract][Full Text] [Related]
27. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.
Masuda T; Hattori N; Senoo T; Akita S; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
Mol Cancer Ther; 2013 Nov; 12(11):2378-88. PubMed ID: 23990114
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
[TBL] [Abstract][Full Text] [Related]
29. Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice.
Ploplis VA; Balsara R; Sandoval-Cooper MJ; Yin ZJ; Batten J; Modi N; Gadoua D; Donahue D; Martin JA; Castellino FJ
J Biol Chem; 2004 Feb; 279(7):6143-51. PubMed ID: 14625301
[TBL] [Abstract][Full Text] [Related]
30. Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.
Jing Y; Kovacs K; Kurisetty V; Jiang Z; Tsinoremas N; Merchan JR
Mol Cancer Res; 2012 Oct; 10(10):1271-81. PubMed ID: 22912336
[TBL] [Abstract][Full Text] [Related]
31. The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.
Kubala MH; DeClerck YA
Cancer Metastasis Rev; 2019 Sep; 38(3):483-492. PubMed ID: 31734763
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.
Takayama Y; Hattori N; Hamada H; Masuda T; Omori K; Akita S; Iwamoto H; Fujitaka K; Kohno N
Cancer Res; 2016 Jun; 76(11):3285-94. PubMed ID: 27197170
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis.
Chen SC; Henry DO; Reczek PR; Wong MK
Mol Cancer Ther; 2008 May; 7(5):1227-36. PubMed ID: 18483310
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
[TBL] [Abstract][Full Text] [Related]
36. Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis.
Teng H; Chopp M; Hozeska-Solgot A; Shen L; Lu M; Tang C; Zhang ZG
PLoS One; 2012; 7(3):e33444. PubMed ID: 22432023
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
[TBL] [Abstract][Full Text] [Related]
38. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
39. The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study.
Thewes M; Elsner E; Wessner D; Engst R; Ring J
Int J Dermatol; 2000 Mar; 39(3):188-91. PubMed ID: 10759957
[TBL] [Abstract][Full Text] [Related]
40. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
Samarakoon R; Higgins PJ
J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
